Uganda launches 3rd phase of HIV vaccine efficacy trials


  • World
  • Wednesday, 16 Dec 2020

KAMPALA, Dec. 16 (Xinhua) -- Ugandan scientists have launched the third phase of HIV vaccine efficacy trials in the central district of Masaka, the country's ministry of health said here Wednesday.

Emmanuel Ainebyoona, spokesperson for the ministry, told Xinhua that the Medical Research Council, the Uganda Virus Research Institute and the London School of Hygiene and Tropical Medicine have enrolled the first two volunteers in the African-led PrEPVacc HIV vaccine efficacy trials to test two ways of HIV prevention and pre-exposure prophylaxis in humans.

"The HIV vaccine has reached its stage-three trials to establish whether the vaccine can protect an individual from HIV," said Ainebyoona.

"The trials, the first of their kind in Africa, are taking place in Uganda, Tanzania, Mozambique and Africa," he added.

PrEPVacc HIV vaccine is an ongoing African-led, European-supported HIV prevention project in four countries in East and Southern Africa from 2018 to 2023.

According to the United Nations Program on HIV/AIDS, the HIV epidemic remains a major public health threat in Uganda with an estimated 1.4 million people living with the virus.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3
   

Did you find this article insightful?

Yes
No

Next In World

Bollywood, streaming giants on edge as Amazon gets flak for hurting religious beliefs in India
Moldova is first European country to receive COVID-19 vaccines under COVAX
France could block vaccine shipments, similar to Italy - Veran
Hungary PM expects spike in COVID hospitalisations as infections spread
Indian farmers plan major road blockade outside Delhi to mark 100th day of protests
Widespread electricity cuts in Myanmar after system failure - utility
Pope Francis departs Rome for risky, historic Iraq tour
Apple probed by UK as App Store payments scrutiny mounts
Australia says inquiry spurred by rape allegations to report findings in November
Japan supercomputer shows doubling masks offers little help preventing viral spread

Stories You'll Enjoy


Vouchers